Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Acrivon Therapeutics, Inc. Common Stock
Market Cap
$85.18M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$85.90M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$84.87M
Operating Margin
-5271.69%
TTM Avg
-2635.84%
3Y Avg
-2669.01%
5Y Avg
-3573.08%
Market Cap
$84.17M
Operating Margin
-3242.47%
TTM Avg
-1621.23%
3Y Avg
-1058.13%
5Y Avg
-747.59%
Market Cap
$87.48M
Operating Margin
-8256.32%
TTM Avg
-7689.73%
3Y Avg
-8755.63%
5Y Avg
-8045.81%
Market Cap
$81.82M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$87.75M
Operating Margin
7.31%
TTM Avg
8.88%
3Y Avg
-4.43%
5Y Avg
-3.84%
Market Cap
$88.21M
Operating Margin
12.60%
TTM Avg
-0.11%
3Y Avg
-11.38%
5Y Avg
-8.86%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acrivon Therapeutics, Inc. Common Stock (ACRV) | $85.18M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.90M | 0.00% | 0.00% | 0.00% | 0.00% |
| Humacyte, Inc. (HUMA)vs › | $84.87M | -5271.69% | -2635.84% | -2669.01% | -3573.08% |
| MediciNova, Inc. (MNOV)vs › | $84.17M | -3242.47% | -1621.23% | -1058.13% | -747.59% |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.48M | -8256.32% | -7689.73% | -8755.63% | -8045.81% |
| Citius Oncology, Inc. (CTOR)vs › | $81.82M | 0.00% | 0.00% | 0.00% | 0.00% |
| CareCloud, Inc. (CCLD)vs › | $87.75M | 7.31% | 8.88% | -4.43% | -3.84% |
| Conexeu Sciences Inc. (CNXU)vs › | $86.43M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 12.60% | -0.11% | -11.38% | -8.86% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.52M | 29.69% | -17.51% | -923.94% | -894.93% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
